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Executive Summary 
As required by Arizona Revised Statues (A.R.S.) §36-2809, the Arizona Department of Health 
Services (ADHS) is submitting this first annual comprehensive statistical report for the Arizona 
Medical Marijuana Program from April 2011 to June 2012.  The report was prepared by ADHS 
in conjunction with the University of Arizona, Mel & Enid Zuckerman College of Public Health. 
 
In November 2010, Arizona voters passed a ballot initiative making Arizona the fourteenth state 
to adopt a medical marijuana law.  Of the 16 states and District of Columbia that have enacted 
medical marijuana programs prior to June 1, 2012, nine have been by ballot initiatives similar to 
Arizona and eight have been through legislative means not requiring voter approval.  
 
Despite being given a short timeline to develop the program, ADHS posted draft rules about a 
month after the initiative's passage, sought public input on the initial rules, posted revised draft 
rules based on comments received, and acquired additional comments during four public hearing 
sessions. The final rules were published on March 28, 2011, and the Arizona Medical Marijuana 
Program went into effect on April 14, 2011. ADHS’ goal throughout the process was to ensure 
the development and administration of the pre-eminent program in the country for medical use of 
marijuana.  
 
For a patient to be eligible to receive a Registry Identification Card, the Arizona law requires that 
the patient first obtain a medical recommendation from a physician who attests that the patient 
meets specified medical criteria.  This report refers to this recommendation as a “certification” of 
a “qualifying patient.”    
 
During April 2011 to June 2012, ADHS received a total of 41,476 applications and approved 
approximately 98% of the applications (40,463). Out of the 40,463 approved applications, 
33,060 (82%) were new applications and 3,689 (9%) were application for renewals. There were a 
total of 29,804 active cardholders, which included 28,977 qualifying patients and 827 caregivers. 
Of the total qualifying patients, approximately 26% (n = 7,702) were female qualifying patients 
and of the total caregivers, 20% (n = 168) were female caregivers. During April 2011 to June 
2012 slightly over 80% (n = 24,191) of the qualifying patients and caregivers (n = 701) were 
authorized to cultivate. Qualifying patients per 1,000 residents were highest in Gila County (9.2), 
followed by Yavapai (8.7) and Coconino (8.4), while Yuma (0.9), Santa Cruz (1.6), and Apache 
(1.9) had the lowest qualifying patients per 1,000 residents.  
 
The majority of the qualifying patients (n = 22,357; 77%) had one debilitating medical condition 
with the remaining 23% reporting two or more conditions. Approximately 70% of the qualifying 
patients (n = 19,631) indicated “severe and chronic pain” as the only debilitating medical 
condition. Four-hundred seventy-five physicians provided certifications to 28,977 patients during 
this time period (a median value of two certifications per physician; however, 10 physicians 
certified 13,336 [~46%] of all patients). 
 
From April 2011 through June 2012, one qualifying patient and six designated caregiver Registry 
Identification Cards were revoked.  During this time period, no dispensary agent cards were 
issued, and no dispensaries were approved to operate. 
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Introduction 
 
1.1 Arizona Medical Marijuana Timeline and Passage of Proposition 
As shown in Table 1, in November 2010, voters passed the Arizona Medical Marijuana Act 
(AMMA). The citizen initiative (Proposition 203) required the Arizona Department of Health 
Services (ADHS) to create a medical marijuana program within 120 days from the certification 
date of official election results. The goal was to create the first truly medical marijuana program 
in the country.1 Staff from across the Department joined together to create a plan. The 
challenging undertaking included Information Technology systems for applications, reporting, 
and validating. Staff combed through the rules in other states to help write the Arizona rules for 
how the program would work, how Arizona residents could apply for the different types of 
licenses, when they could apply, and how to add new debilitating diseases, among other 
important elements. Even though the initiative allowed ADHS to avoid the normal rulemaking 
process, staff asked twice for written public comment and held four public hearings to gather 
public input. On December 17, 2010, ADHS posted the medical marijuana informal draft rules 
for public comment and received comments via an online survey during the comment period 
from December 17, 2010 to January 7, 2011.1 On January 31, 2011, ADHS posted the official 
medical marijuana draft rules for public comment, and received comments via an online survey 
during the comment period from January 31 to February 18, 2011. ADHS also received 
comments at four public meetings held during February 14 to 17, 2011.1  
Table 1. Arizona Medical Marijuana voting results by county 
 
Count Percent Counts Percent
Apache 6,816 36.8% 11,726 63.2% 18,542
Cochise 18,466 46.8% 20,979 53.2% 39,445
Coconino 20,625 53.7% 17,761 46.3% 38,386
Gila 7,800 44.9% 9,554 55.1% 17,354
Graham 2,926 33.1% 5,906 66.9% 8,832
Greenlee 1,101 46.9% 1,248 53.1% 2,349
La Paz 2,023 46.6% 2,319 53.4% 4,342
Maricopa 480,564 49.8% 484,591 50.2% 965,155
Mohave 25,779 49.3% 26,526 50.7% 52,305
Navajo 9,918 35.1% 18,328 64.9% 28,246
Pima 174,591 57.1% 131,017 42.9% 305,608
Pinal 36,942 48.7% 38,928 51.3% 75,870
Santa Cruz 4,840 51.5% 4,560 48.5% 9,400
Yavapai 35,839 44.9% 44,066 55.1% 79,905
Yuma 13,118 40.2% 19,499 59.8% 32,617
Total 841,348 50.1% 837,008 49.9% 1,678,356
No
Proposition 203 (Arizona Medical Marijuana)
County
TotalYes
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1.2 Overview of the Arizona Medical Marijuana Program Requirements 
Licensing Authority 
The AMMA designates ADHS as the licensing authority for the Arizona Medical Marijuana 
Program.  Along with developing the rules and administrative components for the program, 
ADHS is responsible for issuing Registry Identification Cards for qualifying patients (QPs), 
designated caregivers (CGs), and dispensary agents (DAs) and for selecting, registering, and 
providing oversight for nonprofit medical marijuana dispensaries. See Appendix B for reference 
to the Arizona Administrative Code (A.A.C.) and specific time frames for components of the 
program.1 
Qualifying Patient Applications for Registry Identification Cards 
Qualifying patients (QP) began applying for Registry Identification Cards on April 14, 2011. For 
a QP to be eligible to legally possess and purchase marijuana for medical use under Arizona law, 
they must possess a Registry Identification Card.  To obtain a Registry Identification Card, a QP 
must submit to ADHS an application for a Registry Identification Card in the ADHS online 
application system.  Applicants must provide: 
• Personal demographic information 
• Designated CG information (if the applicant is designating a CG) 
• The certifying physician’s information 
• An attestation pledging not to divert marijuana and that the information submitted is true 
and correct 
• An identification document (Arizona Driver’s License, Arizona Identification Card, 
Arizona Registry Identification Card, U.S. Passport Page) 
• A current photograph 
• Physician Certification 
• Documentation for Supplemental Nutrition Assistance Program (SNAP) (if claiming 
SNAP eligible) 
• The application fee  
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Additionally, the QP must answer whether s/he is requesting authorization for cultivating 
marijuana plants for medical use.  Qualifying patients may be authorized to cultivate if they live 
at least 25 miles from the nearest operating dispensary. Registry Identification Cards expire each 
year, and the QP must be re-evaluated by a physician and submit applications (including fees) 
yearly. 
Debilitating Medical Conditions 
Debilitating medical conditions for use of medical marijuana in Arizona are the following: 
cancer, glaucoma, HIV, AIDS, Hepatitis C, Amyotrophic Lateral Sclerosis, Crohn’s disease, 
agitation of Alzheimer’s disease, or a chronic or debilitating disease or medical condition (or the 
treatment of such a condition) that causes cachexia or wasting syndrome, severe and chronic 
pain, severe nausea, seizures (including those characteristic of epilepsy), severe or persistent 
muscle spasms (including those characteristic of multiple sclerosis), or a debilitating medical 
condition or treatment approved by ADHS under A.R.S. §36-2801.01 and A.A.C. R9-17-106.  
Pursuant to A.A.C. R9-17-106, ADHS accepts petitions to add 
a debilitating medical condition to the list of debilitating 
medical conditions for the Medical Marijuana Program in 
January and July of each year.  In January 2012, ADHS 
reviewed several conditions from petitions received including 
Post Traumatic Stress Disorder (PTSD), Depression, 
Migraines, and Generalized Anxiety Disorder.  ADHS held a 
public hearing on May 25, 2012 to collect public comments on 
these medical conditions.  After consideration of the evidence 
submitted and the public hearing, ADHS rejected these 
petitions to add new qualifying conditions to the list of 
debilitating medical conditions.  In July 2012, ADHS again 
accepted petitions but no conditions moved forward to a public 
hearing.  ADHS will next accept petitions in January 2013.  
To assist ADHS in the decision-making process of adding debilitating medical conditions, the 
University of Arizona’s College of Public Health completed an evidence review on each of the 
four debilitating medical conditions submitted for consideration: PTSD, migraines, anxiety, and 
depression. These reports are posted on the ADHS website and were presented to the ADHS 
Medical Committee prior to their submission to the ADHS Director for his consideration.  The 
University also established a system of surveillance for new studies on these four topics so that 
any new evidence will be located monthly and placed into a data bank. Additionally, they have 
begun three new evidence reports: two on safety issues including cyclical vomiting and 
psychosis and one on effectiveness of medical marijuana on wound healing.  
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Physicians 
As part of the application for a Registry Identification Card as a QP, an individual must have a 
written certification from a physician making or confirming diagnosis of the debilitating medical 
condition(s).  Certifying physicians may be:   
• a doctor of medicine (Allopath) who holds a valid and existing license to practice 
medicine, pursuant to Title 32, Chapter 13 or its successor 
• a doctor of osteopathic medicine who holds a valid and existing license to practice 
osteopathic medicine pursuant to Title 32, Chapter 17 or its successor  
• a naturopathic physician who holds a valid and existing license to practice naturopathic 
medicine pursuant to Title 32, Chapter 14 or its successor 
• a homeopathic physician who holds a valid and existing license to practice homeopathic 
medicine pursuant to Title 32, Chapter 29 or its successor 
The certifying physician must document on the physician certification form that s/he has 
performed the following for each QP: 
• Has made or confirmed a diagnosis of a debilitating 
medical condition 
• Has established and is maintaining a medical record for 
the QP 
• Has conducted an in-person physical exam within the 
last 90 calendar days appropriate to the QP’s presenting 
symptoms and the debilitating medical condition 
diagnoses or confirmed 
• Has reviewed the QP’s medical records including those 
from other treating physicians for the previous 12 
months 
• Has reviewed the QP’s profile on the Arizona Board of Pharmacy Controlled Substances 
Prescription Monitoring Program database 
• Has explained the potential risks and benefits of the medical use of marijuana 
• Whether s/he has referred the QP to a dispensary (this has not been applicable since there 
were no operating dispensaries during this report period) 
The physician must also attest, by signature, that it is the physician’s professional opinion that 
the QP is likely to receive therapeutic or palliative benefit from the patient’s medical use of 
marijuana.   
Clinical Trials 
When QPs apply for a Registry Identification Card, they may ask to be notified of any available 
clinical trials.  Every quarter, ADHS sends an email to those individuals who have selected to 
The physician must attest, by 
signature, that it is the 
physician’s professional 
opinion that the qualifying 
patient is likely to receive 
therapeutic or palliative 
benefit from the patient’s 
medical use of marijuana.   
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receive this information.  The email refers the QP to the United States National Institutes of 
Health (NIH) website for clinical trials (www.clinicaltrials.gov).   NIH has developed a 
searchable online site to facilitate distribution of information on clinical trials.  The database is 
searchable by disease or condition or by intervention (such as cannabis use) or other factors such 
as the physical location of the study.  Additionally, the University of Arizona has provided a list 
of available clinical trials which is posted on the ADHS website. 
Minor Patients 
Minor patients (younger than 18 years of age) can qualify for the Arizona Medical Marijuana 
Program.  However, minor patient requirements include two physician certifications during the 
application process.  Additionally, the minor patient’s custodial parent or legal guardian must be 
designated as the minor patient’s designated caregiver (CG).  This CG provides parental consent 
to the minor patient’s use of medical marijuana and controls the dosage, acquisition and 
frequency of use. 
Designated Caregiver Applications for Registry Identification Cards 
Designated caregivers (CGs) must also hold Registry Identification Cards for each QP who has 
designated them as a CG.  In Arizona, CGs, who must be at least 21 years of age, are limited to 
serving no more than five QPs.  The CG can cultivate, if authorized to do so by his or her QPs, 
up to 12 marijuana plants per patient.   
Similar to QP applications, an individual being designated as a CG by a QP must provide 
personal demographic information, an identification document, and a current photograph.  The 
CG must also provide the application number from the patient s/he is linking with and complete 
a signed statement agreeing to assist the QP with the medical use of marijuana, pledging not to 
divert marijuana to any person who is not allowed to possess marijuana, and stating that the 
individual has not been convicted of an excluded felony offense.  The CG must also submit two 
original sets of fingerprints to ADHS to complete the application.  If the CG is found to have had 
an excluded felony offense on his or her criminal history, ADHS will seek to revoke the 
designated CG’s card(s). 
Registration Fees 
The fees are listed in the A.A.C. R9-17-102 and include:  
• $150 for an initial or a renewal Registry Identification Card for a QP. QPs may be 
eligible to pay $75 for initial and renewal cards if they currently participate in SNAP. 
• $200 for an initial or a renewal Registry Identification Card for a CG for each QP (up to 
five patients).  
• $500 for an initial or a renewal Registry Identification Card for a DA.  
• $5,000 for an initial dispensary registration certificate.  
• $1,000 for a renewal dispensary registration certificate.  
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• $2,500 to change the location of a dispensary or cultivation facility.  
• $10 to amend, change, or replace a Registry Identification Card.  
Non-Profit Medical Marijuana Dispensaries 
Non-profit medical marijuana dispensaries (dispensaries) are 
entities that acquire, possess, cultivate, manufacture, deliver, 
transfer, transport, supply, sell, and dispense medical marijuana.  
For the first year, legal action delayed the dispensary 
application and registration process in Arizona. The Arizona 
Medical Marijuana Act and the supporting Administrative Code 
delineates the process and regulations for medical marijuana 
dispensary certification, policies, medical director 
responsibilities and functions, DA registration, and other 
restrictions and precautions.  
ADHS may not issue more than one dispensary registration certificate for every ten licensed 
pharmacies in Arizona, except if necessary to ensure ADHS issues at least one dispensary 
registration certificate in each county.  In 2011, the maximum number of potential dispensaries 
in Arizona was 126. 
From May 14 through May 25, 2012, ADHS accepted applications for non-profit medical 
marijuana dispensaries.  Four hundred eighty-six applications were received.  Applicants were 
required to submit an application including components such as policies and procedures, a 
business plan, zoning compliance and property ownership documentation, and an application fee.  
Additional evaluation criteria were also accepted and included whether any individual who had a 
20% or more interest in the dispensary was not the applicant or principal officer or board 
member of the dispensary and whether the applicant submitted proof of possessing $150,000 to 
begin operating. 
For the first year of the initial allocation process (2012), dispensary registration certificates were 
issued based on one dispensary per Community Health Analysis Area (CHAA).  If there was 
more than one dispensary registration certificate application for a CHAA that was complete and 
in compliance, ADHS issued dispensary registration certificates using a random selection 
process.  ADHS held a lottery on August 7, 2012, and a total of 98 registration certificates were 
allocated through this process.  The lottery process was shown live via streaming video through 
the ADHS website.  ADHS utilized an outside auditing firm to oversee the lottery process.  
Appendix C describes the Medical Marijuana Dispensary Application Drawing Procedures.  
After the conclusion of the drawing, the outside auditing firm also provided a review of how 
ADHS applied these operating procedures (Appendix D, Independent Accountant’s Report on 
Applying Agreed-Upon Procedures). 
Non-profit medical marijuana 
dispensaries (dispensaries) are 
entities that acquire, possess, 
cultivate, manufacture, deliver, 
transfer, transport, supply, sell, 
and dispense medical 
marijuana.   
 Page | 8  
 
Prior to opening, dispensaries that received dispensary registration certificates are required to 
submit an application to operate at least 60 days before the expiration date of the certificate 
(August 7, 2013).  Additionally, Approval to Operate (ATO) applications submitted to ADHS 
must include elements such as site plans, floor plans, conditional use permits, special use 
permits, or certificates of occupancy.  The dispensary must also receive an inspection during 
which ADHS will verify, among other requirements, the inventory control system, security, 
systems to establish, maintain, and ensure confidentiality of QP records, authorized personnel 
verification, product labeling and analysis, and cleanliness and sanitation. 
The second annual report will cover appropriate dispensary information once dispensaries in 
Arizona are operational.  
Non-Profit Medical Marijuana Dispensary Agents 
Non-Profit Medical Marijuana Dispensary Agents (DAs) are principal officers, board members, 
employees or volunteers of non-profit medical marijuana dispensaries, and must be at least 21 
years of age.  Dispensary Agents perform many functions including: 
• Dispensing medical marijuana 
• Verifying QP and CG Registry Identification Cards before dispensing 
• Maintaining QP records 
• Maintaining an inventory control system 
• Ensuring that medical marijuana has the required product labeling and analysis 
• Providing required security 
• Ensuring that edible food products sold or dispensed are prepared only as permitted 
• Maintaining the dispensary and cultivation site in a clean and sanitary condition 
DAs, similar to CGs, cannot have been convicted of an excluded felony offense.  ADHS collects 
two original sets of fingerprints and processes the fingerprints to determine if the individual has 
an excluded felony offense.  A DA is required to be registered with ADHS before volunteering 
or working at a dispensary.  Dispensaries must apply for a Registry Identification Card for each 
DA.   
During the time period for which the data have been analyzed provided in this report (April 14, 
2011 through June 15, 2012), there were zero DA Registry Identification Cards issued. 
Appendix A provides an overview of the revenue and expenditures since the program’s inception 
in April 14, 2011 until June 30, 2012. 
Program Project Contracts and Interagency Service Agreements 
Since the program’s inception, ADHS has partnered with external agencies, private firms, and 
institutions to assist in program development and execution.  Below is a summary of some of the 
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major work projects associated with the initial development and continued implementation of the 
medical marijuana program. 
• An Invitation for Bid (IFB) was conducted in 2011 to secure Medical Marijuana 
Registration Cards, Supplies and Equipment.  The Contract issued subsequent to the IFB 
was for the purchase of pre-printed card stock, color printers, holographic image laminate 
overlay, software to integrate with the ADHS ITS database, technical support, equipment 
maintenance, training and printer supplies. The Contract was awarded to Electronic 
Security Concepts on March 21, 2011.  It is valid through March 20, 2014, and has two 
one-year extensions available.  To date, ADHS has spent $152,860.65. 
• In preparation for the August 7, 2012 
dispensary lottery process, three Atomic 
Table Top Bingo Blowers (one for testing, 
one for use at the Dispensary Drawing and 
one backup) and 15 sets of bingo balls were 
purchased for $4,279 with the Procurement 
Office Purchasing Card.  Internet research 
was conducted to find a certified machine 
that would randomly dispense lottery-type 
balls for the 126 CHAAs and that was also 
cost effective.  Some of the larger free-
standing machines cost up to $10,000 each.  
• In preparation for the August 7, 2012 dispensary lottery process, Chain-of-Custody 
Evidence Bags were purchased using the Finance Office for Public Health Prevention 
Purchasing Card.  The bags cost $99. Procurement provided the research and 
quotes.  These 15” by 20” clear, tamper-proof evidence bags were used to seal the groups 
of balls for each CHAA drawing and the non-awarded balls were sealed back into a new 
bag by CHAA number.  The Automatic Table Top Bingo Blowers and sealed evidence 
bags were kept under lock and key in the Office of Procurement at ADHS.  
• A Purchase Order under State Contract SCC060006-2 with Henry & Horne, CPA was 
established for $10,159.  The CPA firm provided two individuals to assist with 
development and review of the dispensary random selection process, establishment of 
secure bags of balls for each CHAA drawing, attendance at the Medical Marijuana 
Dispensary drawing to ensure that the written procedures were followed, and provision of 
a final Management Report of the entire process. 
• An Interagency Service Agreement (ISA), ADHS12-017291, for Research and 
Evaluation Services was executed with the University of Arizona College of Public 
Health on February 12, 2012 for five years.  The intent of the ISA is to provide agency-
wide services, but currently the focus is on medical marijuana.  The University assists 
with review of clinical trials, review and evaluation of requests to add new debilitating 
medical conditions, preparation of Continuing Medical Education curriculum for 
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physicians related to medical marijuana, and review and evaluation of medical marijuana 
data and preparation of the Annual Report.  The value of the medical marijuana portion 
of the ISA is $200,000.  
• An ISA, HS352036, with the Arizona Board of Pharmacy was executed on September 21, 
2012 for five years (if funding is available).  The ISA funds upgrading of the Controlled 
Substances Prescription Monitoring Program database to improve physicians’ ability to 
register online and check the patient’s profile on the database. The funds allow for one 
(1) Full-time Equivalent (FTE) Pharmacist to manage data and provide research, analysis, 
ad hoc queries and expanded reporting, including necessary office equipment.  The 
current amount encumbered is $284,325.00. 
• An ISA, ADHS13-028141, with The Center for Toxicology and Pharmacology Education 
and Research (CTPER) was sent to the University of Arizona this October for review and 
input.  This ISA is still pending. The intent is to provide a collaborative venue between 
the Poison and Drug Information Centers at the University of Arizona (Contractor) 
College of Pharmacy and Banner Good Samaritan Medical Center in Phoenix. The 
objective of the ISA is a multi-organizational collaborative center of excellence to 
provide expertise, education and research in the areas of medical toxicology, 
pharmacology, and medication safety utilizing the 24-hour access of specially trained 
healthcare professionals to provide medication and patient safety information to the 
licensed users and dispensers in Arizona. The current projected budget is $900,000 per 
year. 
Arizona Medical Marijuana Program Outside Counsel and Lawsuits 
The majority of the medical marijuana program’s legal matters are handled by the Arizona 
Attorney General’s Office (AGO).   However, in order to avoid the potential of overtaxing the 
limited resources of ADHS and AGO, in August 2012, 
ADHS made a request for the appointment of outside 
counsel.  The appointment was requested to allow outside 
counsel to assist ADHS with the numerous medical 
marijuana-related administrative appeals and lawsuits, as 
well as possibly represent ADHS in informal settlement 
conferences, administrative hearings and court 
proceedings. Therefore, in late August 2012, through the AGO, the law firm Sherman & 
Howard, L.L.C. was appointed as outside counsel to ADHS.   
Several lawsuits have been filed concerning the implementation of the Arizona Medical 
Marijuana Act.  A scanned copy of the complaint for each lawsuit is available on the ADHS 
website.  As of the date of this Annual Report, the current lawsuits include: 
• Johanna Dispensaries v. ADHS: LC2012-000544 
• Charise Voss Arfa v. ADHS: CV2012-014816 
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• Arizona Organix v. ADHS: CV2012-054733 
• White Mountain Health Center v. ADHS: CV2012-053585 
• Serenity v. ADHS: LC2011-000410 
• Elements v. ADHS: CV2011-011288 
• Compassion First v. Arizona: CV2011-011290 
• Sobol v. Arizona: CV2011-053246 
• Arizona v. 2811: CV2011-014508 
• Arizona v. USA: 11-01072 
1.3 Comparisons of Arizona's Medical Marijuana Act with Other States and Districts 
Arizona was the fourteenth state to pass medical marijuana legislation. Currently, sixteen other 
states and the District of Columbia (DC) have adopted legislation.3  Since the 1970's, numerous 
cases of marijuana possession and use for medicinal purposes proceeded through the courts with 
varying outcomes.2  In 1996 with a 56% majority vote on a ballot initiative, California was the 
first state to pass legislation allowing for medical use of marijuana.  At this time, an additional 
twelve states have legislation that has been introduced or proposals in process.2  A summary is 
provided in Table 2. 
Table 2. Summary of U.S. States and districts with medical marijuana legislation3-7 
Year Passage Margin State Passing Medical Marijuana Legislation 
1996 56% California 
1998 AK - 58% 
DC - 69% 
NV - 65% 
OR - 56% 
WA - 59% 
Alaska; District of Columbia - intervention by Congress -law did not 
go into effect until July 2010; Nevada - legislation additions in 20006; 
Oregon; Washington 
1999 ME - Legislature Maine – affirmative defense legislation broadened by public law in 
20094 
2000 Co - 54% 
HI - HI Legislature 
Colorado; Hawaii 
2003 Legislature Delaware - limited affirmative defense legislation broadened in 2011
2004 MT - 62% 
VT - VT 
Legislature 
Montana - additional restrictions added in 2011; Vermont 
2006 RI - RI Legislature Rhode Island7 
2007 NM - NM 
Legislature 
New Mexico5 
2008 62% Michigan 
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Year Passage Margin State Passing Medical Marijuana Legislation 
2009 61% Maine – passed public medicinal use legislation, fully clarified and 
implemented program in 20104 
2010 AZ - 50.1% 
NJ - NJ Legislature 
Arizona; New Jersey 
2011 DE - DE Senate 
MD - MD General 
Assembly 
Delaware, cards to be issued in 2012; dispensaries in 2013; Maryland 
affirmative defense legislation 
2012 CO – Initiative 
Passed, margin 
TBD 
CT - Senate bill 
WA – Initiative 
Passed, margin 
TBD 
Colorado – Legalization not limited to medical usage 
Connecticut (6/1/12)2 
Washington – Legalization not limited to medical usage 
States with proposed Medical Marijuana Legislation as of 8/22/122: 
Arkansas; Illinois; Massachusetts; Missouri; New York; Ohio; Pennsylvania 
States with Medical Marijuana Legislation that failed in 20122: 
Alabama; Idaho; Indiana; Iowa; Kansas; Maryland (currently affirmative defense only); Mississippi; 
New Hampshire; Oklahoma; Tennessee; West Virginia; Wisconsin 
Within the sixteen states and District of Columbia with legislation, the acts are variable, 
including primary issues such as the entity that oversees the programs, use of patient or CG 
identification cards, physician and/or CG oversight, cultivation and dispensary limitations, 
qualifying conditions for use, and protection limits and access.3 The legislation passed in 
Maryland does not set up a medical marijuana program per se, but provides an affirmative 
defense and potential sentencing mitigation for possession. Maryland also does not require a 
physician's certification. Within the legislation passed in California, physicians can recommend 
marijuana use for any condition. In all other jurisdictions with legislation, physicians must 
certify patients for medical marijuana use for one or more of a set list of qualifying conditions.3 
All states with the exceptions of Maryland and Washington utilize or are creating a system to 
issue identification cards for medical marijuana QPs and CGs, if appropriate. For patients in 
California and Maine, identification cards are optional.3 The administrative entity that has the 
authority to issue identification cards varies among the states.  For the majority of states, a 
Department of Health entity is the authority.  However, for Hawaii and Vermont, it is the 
Department of Public Safety, and for Michigan it is the Department of Licensing and Regulatory 
Affairs.3 
Physicians play an important role in either recommending the medical use of marijuana or 
certifying that a patient has one or more of the serious conditions or symptoms specified in the 
legislation/initiative to qualify for its use in every state except Maryland (affirmative defense 
legislation only). An affirmative defense in such a situation would allow someone charged with 
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criminal possession/use of marijuana to present evidence of 
medical qualifications to avoid conviction.2 In California, 
physicians can recommend medical marijuana for one or 
more of several listed conditions and "...any other illness for 
which marijuana provides relief." 
Additional legislation in the states and District of Columbia 
specify requirements for minor (under 18 years of age) 
patients. In Washington, the parent or legal guardian is 
responsible for a minor patient. In Alaska, Oregon, Maine, 
Hawaii, Nevada, Rhode Island, New Mexico, New Jersey, 
and the District of Columbia, the minor only qualifies with 
parent/legal guardian consent and if the adult controls the dosage, acquisition and frequency of 
use.3  In Vermont, the minor patient must have a parent or guardian also sign the application. 
Arizona is similar to Colorado, Montana, and Michigan in requiring the minor to have two 
physician authorizations along with parental consent.1-3 Additionally, the adult must control the 
dosage, acquisition and frequency of use. In Delaware, all medical marijuana patients must be 18 
years of age or older. As Maryland does not currently have a medical marijuana program per se, 
the potential for legal medicinal marijuana use among minors is unclear. 
On November 6, 2012, Colorado and Washington passed by voter initiative legalization of 
marijuana not limited to medical usage.  Final vote counts were not yet available at the time of 
this publication. 
Debilitating and qualifying conditions also vary among states and the District of Columbia that 
have enacted medical marijuana programs. Table 3 on the following page provides a summary of 
qualifying debilitating conditions by state/District.  As of November 6, 2012, no condition is 
required to qualify an individual to consume marijuana in Colorado and Washington, and 
therefore, these states were removed from this table.
Physicians play an important 
role in either recommending 
the medical use of marijuana 
or certifying that a patient has 
one or more of the serious 
conditions or symptoms 
specified in the legislation to 
qualify for its use…. 
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Table 3. Comparison of qualifying conditions among states and districts with medical marijuana legislation2-7  
Condition AK AZ CA DE DC HI ME MD MI MO NV NJ NM OR RI VT
AIDS X X X X X  X  X X X  X X X X 
ALS  X  X   X  X   X X    
Alzheimer’s  X  X   X  X     X X  
Cancer X X X  X  X  X X X X X X X X 
Cachexia X X    X  X X X X  X X X X 
Chronic/intractable /Severe Pain X X X   X  X X X X X X X X X 
Cirrhosis    X             
Crohn's  X     X  X X   X    
Epilepsy                 
Glaucoma  X X  X  X  X X X X  X X  
Hepatitis C  X     X      X  X  
HIV X X  X X  X  X X X  X X X X 
Hospice admittance / terminal ill          X  X     
Inflammatory bowel disease            X     
Migraine   X              
MS           X  X X   X 
Muscle spasms X X X  X X X X X  X X  X X  
Nail patella       X  X        
Nausea X X  X  X X X X X X   X X X 
Peripheral neuropathy          X   X    
PTSD    X         X    
Seizures X X  X  X X X X X      X 
Spasticity / Spinal cord damage             X    
Treatment w/ AZT, chemo, 
protease inhibitors, or radiotherapy 
    X            
Intractable vomiting          X   X    
Other: Doctor states   X         X     
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Methodology 
Data on all cardholders (i.e., QPs and CGs) are collected via a secure electronic web-based 
application system. The information collected by ADHS for purposes of administering the 
program is confidential by statute (A.R.S. §36-2810), exempt from public records requests under 
A.R.S. Title 39, Chapter 1, Article 2, exempt from requirements for sharing with federal agencies 
under A.R.S. §36-105, and not subject to disclosure to any individual or public or private entity, 
except as necessary for authorized employees of ADHS to perform official duties of the 
department. 
2.1 Data Sources 
The data for this annual report are derived from the information collected via an electronic web-
based system for QPs and CGs. A de-identified dataset for the period starting April 14, 2011 to 
June 15, 2012 was provided by ADHS to the University of Arizona. The de-identified dataset 
contained information for all active cardholders during this time period. This de-identified 
dataset contained 29,804 records that included both QPs (n = 28,977) and CGs (n = 827) and 
information relevant to their application as required by A.R.S. §36-2809 for preparation of the 
annual report. 
2.2 Measures 
The measures reported here were pre-populated by ADHS to ensure confidentiality and mostly 
relate to the QPs’ and CGs’ characteristics: 
• Gender of the QP and CG;  
• Age in years for QPs and CGs (<18, 18-30,  31-40, 41-50, 51-60, 61-70, 71-80, and 81+); 
• County of residence; 
• Authorized to cultivate or cultivation status of a QP; 
• Application type (new, renewal); 
• Card status (active, revoked, date of issue, date of expiration); 
• Entity type (i.e. QP, QP minor, CG, CG minor);  
• Debilitating medical conditions (i.e. Alzheimer, Cancer, Glaucoma, HIV/AIDS, HEPC, 
Sclerosis, Crohn’s Disease, Cachexia, Severe and Chronic Pain, Nausea, Seizures, 
Muscle Spasms and other specific conditions); 
• Clinical trial status; 
• SNAP eligibility; 
• Homelessness status; and 
• Physician specialization 
Most of the measures in this report comprise of simple frequencies (counts) and percentages. 
However, where appropriate, measures of center and spread (i.e. averages, standard deviation, 
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median, and inter-quartile ranges) are included along with rates. ADHS analyzed data on 
physicians due to confidentiality considerations, and the analysis has been included in this report 
to satisfy the requirements of the annual report. 
During this time period, no dispensary was authorized by ADHS to operate, and hence, the report 
does not discuss this in detail.  
2.3 Analytic Procedures 
Where applicable both univariate and bivariate statistics are presented.  Rates and chi-square 
tests were estimated using SAS v9.2 2008 software. Population denominators for 2011 were 
obtained from ADHS vital statistics8. ADHS estimated ‘physician certification rates’ based on 
data obtained from the Arizona Medical Board, Arizona Board of Naturopathic Medicine, and 
Arizona Board of Homeopathic Medicine for all active licenses as of May 2012. The 
denominator is comprised of all qualified physician certifiers of medical marijuana as defined in 
A.R.S. §36-2801(12). As of May 2012, there were a total of 25,664 physician certifiers in the 
four categories: Doctor of Medicine (MD; n = 22,111), Doctor of Osteopathic Medicine (DO; n 
= 2,594), Doctor of Naturopathic Medicine (NMD; n = 1,765), and Doctor of Homeopathic 
Medicine (HMD; n = 84). Physician certification rates were estimated using actual number of 
physicians providing certifications for qualifying medical marijuana patients (i.e. numerator) 
divided by the total number of physicians in the population that could provide a certification in 
that specific category or specialization.  
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Results 
Cumulative reports posted by ADHS for all QP applications received from April 14, 2011 to 
June 30, 2012 were based on applications alone. During this period, a total of 41,476 
applications were received and approximately 98% of the applications (40,463) were approved. 
Out of the 40,463 approved applications, 33,060 (82%) were new applications and 3,689 (9%) 
were applications for renewals. Along with QP and CG initial and renewal applications, any 
change in primary information or status (such as designating/changing a CG or requesting a 
change in authorization to cultivate) requires submission of an application.  A key difference in 
the numbers of applications received versus the number of active cardholders is the fact that an 
individual can have more than one application while cardholders are typically individuals and 
usually counted once in the system.  
The results discussed in this report provide an overview of the active cardholders from April 
2011 to June 2012. During this time period, there were a total of 29,804 active cardholders that 
included both QPs (n = 28,977) and CGs (n = 827). Figure 1 below and Figure 2 on the 
following page provide an overview of the monthly applications of active cardholders during the 
April 2011 through June 2012 time period.  
Figure 1. Arizona Medical Marijuana QP monthly applications of active cardholders from April 
2011 through June 2012
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preserve scalability.
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It is evident from Figure 1 that there has been an increase in the number of cardholders for QPs 
from December of 2011 until April of 2012 (~184%). The same increasing pattern is evident for 
designated CGs (see Figure 2). The number of cardholders increased monthly by approximately 
78% from December 2011 until April of 2012. It is important to note that a CG can have up to 
five QPs, and further, an individual can be a QP and/or a CG. Hence, they may be counted as a 
QP and a CG. Because the CG status can change with time, to estimate a ‘true count’ of the 
number of individuals who are both CGs and QPs is difficult. One estimate from ADHS suggests 
that at any given time there are 500 individuals who are both QPs as well as CGs.  
Figure 2. Arizona Medical Marijuana designated caregiver monthly applications of active 
cardholders during April 2011 to June 2012 
  
The following sections detail the characteristics of QPs, CGs, and certifying physicians. 
  
25
42
65 63
59
55
60
54
62
97
107
138
0
20
40
60
80
100
120
140
160
Jun-11 Jul-11 Aug-11 Sep-11 Oct-11 Nov-11 Dec-11 Jan-12 Feb-12 Mar-12 Apr-12 May-12
# 
of
 D
es
ig
na
te
d 
C
ar
eg
iv
er
s
Arizona Medical Marijuana monthly counts of Designated Caregivers during April 2011 to June 2012 
Note: Counts for June 2012 were combined with May 2012 to preserve scalability.
 Page | 19  
 
3.1 Characteristics of Qualifying Patients and Designated Caregivers  
The Arizona Medical Marijuana Program collects a variety of patient data at the time of 
application that includes date of birth, gender, county of address, debilitating conditions, and 
details of recommending physician as per AMMA requirements. Table 4 outlines the 
demographic characteristics of QPs and CGs by age and gender. Twenty-six percent of the QPs 
were females (n = 7,702) and 20% of the CGs were females (n = 168) while a majority of the 
QPs and CGs were males. On average, females were more likely to be older compared to males, 
irrespective of whether they were a QP and/or a CG.  
Table 4. Demographic characteristics of qualifying patients and caregivers 
  
Approximately, 16% of the QPs (n = 4,689) applied under SNAP eligibility for a reduced fee for 
a card during this time period. Of those who were SNAP eligible, the majority (n = 2,916 or 
62%) were males. 
Figure 3 on the following page gives an overview of the cultivation status by gender for QPs and 
designated CGs. The AMMA does not stipulate the place of cultivation for a QP and/or a 
designated CG, and therefore, one cannot infer that an individual cardholder actually cultivates 
marijuana in the same place as his or her residence. From April 2011 to June 2012, slightly over 
80% (n = 24,191) of the QPs and CGs (n = 701) were authorized to cultivate. Males were more 
likely than females to receive authorization to cultivate marijuana, irrespective of whether they 
were a patient and/or a CG. 
Female Males Female Male
<18 years 2 (0.0%) 18 (0.1%) NA NA
18-30 years 1,492 (19.4%) 6,186 (29.1%) 32 (19.0%) 186 (28.2%)
31-40 years 1,383 (18.0%) 4,728 (22.2%) 34 (20.2%) 195 (29.6%)
41-50 years 1,624 (21.1%) 3,616 (17.0%) 40 (23.8%) 120 (18.2%)
51-60 years 2,117 (27.5%) 4,033 (17.0%) 44 (26.2%) 104 (15.8%)
61-70 years 893 (11.6%) 2,350 (11.0%) 15 (8.9%) 50 (7.6%)
71-80 years 151 (2.0%) 301 (1.4%) 3 (1.8%) 4 (0.6%)
81+ years 40 (0.5%) 43 (0.2%) 0 0
State Totals 7,702 (26.6%) 21,275 (73.4%) 168 (20.3%) 659 (79.7%)
Mean (SD )* 45.4 (14.1 ) 41.5 (14.7 ) 44.2 (12.5 ) 39.9 (12.5 )
Note: An individual can be both a qualifying patient and a designated caregiver
*Average age of  qualifying patients and caregivers was significantly higher for females 
compared to males.
Qualifying Patients 
(N = 28,977)
Caregivers
(N = 827)Age groups
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Figure 3. Arizona Medical Marijuana qualifying patients’ and designated caregivers’ 
cultivation status by gender 
 
Table 5 on the following page provides an overview of QPs and CGs by county of residence 
along with their cultivation status. Expressing the number of medical marijuana QPs as a 
proportion of the population in the county is a more appropriate reflection of the prevalence of 
cardholders than a simple proportion. For instance, while Maricopa County had the largest 
percent of QPs (n = 18,001; ~62%), followed by Pima County (n = 3,480; 12%), they are not 
reflective of the total population. As per ADHS estimates, the estimated population for Maricopa 
County in 2011 was 3,843,370.8 Maricopa County had 4.7 QPs per 1000 residents, and Pima 
County had 3.5 QPs per 1000 residents, compared to the state average of 4.5 per 1000 residents. 
Per capita QPs was highest in Gila County (9.2 per 1000 residents), followed by Yavapai (8.7 
per 1000 residents), and Coconino (8.4 per 1000 residents), while Yuma (0.9 per 1000 residents), 
Santa Cruz (1.6 per 1000 residents), and Apache (1.9 per 1000 residents) had the lowest rates 
among the counties.  
The same was true for cultivation status with Gila County (8.3 per 1000 residents), followed by 
Yavapai (7.6 per 1000 residents), and Coconino (6.9 per 1000 residents).  
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Table 5. Arizona medical marijuana qualifying patients, designated caregivers and their 
cultivation status by county of residence8 
 
 
3.2 Nature of Debilitating Medical Conditions among Qualifying Patients  
As per AMMA requirements, ADHS collects information about 13 debilitating medical 
conditions: (i) cancer; (ii) Hepatitis C; (iii) cachexia; (iv) seizures; (v) glaucoma; (vi) sclerosis; 
(vii) Alzheimers; (viii) severe and chronic pain; (ix) muscle spasms; (x) HIV; (xi) AIDS; (xii) 
Crohn's disease; and (xiii) nausea. Certifying physicians can select more than one of these 13 
conditions. Table 6 on the following page provides an overview of the unique debilitating 
medical conditions of the QPs during this time period. 
From April 2011 to June 2012, a majority of the QPs (n = 22,357; 77%) had one qualifying 
debilitating medical condition, followed by approximately 19% (n = 5,379) having two 
conditions, and approximately 4% (n = 1,241) having three or more conditions. By way of 
comparison, 67.7% of the QPs (n = 19,631) indicated “severe and chronic pain” as the only 
debilitating medical condition while other top unique debilitating medical conditions included 
Hepatitis C (n = 605; 2.1%), Cancer (n = 467; 1.6%), muscle spasms (n = 420; 1.4%), and 
nausea (n = 389; 1.3%). Among those who indicated multiple conditions, the majority of the QPs 
had at least two of the listed debilitating conditions, with severe and chronic pain as one of those 
two conditions.  
Counts Percent
QPs per 
1000 
residents
Counts Percent
Caregivers 
per 1000 
residents
Counts Percent
Cultivation 
status per 1000 
residents
Apache 71,991 138 0.5% 1.92 0 0.0% 0.0 131 94.9% 1.82
Cochise 130,537 344 1.2% 2.64 7 0.8% 0.1 293 85.2% 2.24
Coconino 134,162 1,124 3.9% 8.38 28 3.4% 0.2 927 82.5% 6.91
Gila 53,577 494 1.7% 9.22 7 0.8% 0.1 445 90.1% 8.31
Graham 37,710 113 0.4% 3.00 3 0.4% 0.1 96 85.0% 2.55
Greenlee 8,380 43 0.1% 5.13 1 0.1% 0.1 39 90.7% 4.65
La Paz 20,730 95 0.3% 4.58 2 0.2% 0.1 90 94.7% 4.34
Maricopa 3,843,370 18,001 62.1% 4.68 600 72.6% 0.2 14,760 82.0% 3.84
Mohave 200,417 1,393 4.8% 6.95 14 1.7% 0.1 1,306 93.8% 6.52
Navajo 107,226 446 1.5% 4.16 6 0.7% 0.1 414 92.8% 3.86
Pima 986,081 3,480 12.0% 3.53 73 8.8% 0.1 2,871 82.5% 2.91
Pinal 384,231 1,012 3.5% 2.63 29 3.5% 0.1 856 84.6% 2.23
Santa Cruz 48,088 77 0.3% 1.60 5 0.6% 0.1 58 75.3% 1.21
Yavapai 211,247 1,842 6.4% 8.72 48 5.8% 0.2 1,594 86.5% 7.55
Yuma 200,431 190 0.7% 0.95 2 0.2% 0.0 170 89.5% 0.85
Unknown 185 0.6% 2 0.2% 141 76.2%
State Totals 6,438,178 28,977 100 4.47 827 100 0.12 24,191 83.5% 3.76
Authorized to cultivate
Residence County
Qualifying Patients (QPs) Caregivers
Estimated 
Population in 
2011
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Table 6. Reported debilitating medical conditions by qualifying patients of medical marijuana 
 
With regards to debilitating medical conditions, age and gender play a significant role, and the 
following paragraphs detail the nature of debilitating conditions for QPs from April 2011 to June 
2012 time periods. For purpose of brevity, debilitating medical conditions were classified in two 
broad categories: a) unique; and b) two or more conditions. This type of classification allowed 
examining any association between age and gender with one or more debilitating condition.  
Figure 4 and Figure 5 on the following page display the debilitating medical conditions of the 
QPs by age and gender. Qualifying patients who indicated only one unique debilitating medical 
condition were more likely to be younger (average age 42 + 14.6 years). Seventy eight percent of 
the males indicated one unique debilitating condition compared to 74% of females, while 26% of 
females indicated having two or more debilitating conditions compared to 22% of males. In 
general, females were 26% more likely than males to indicate two or more debilitating 
conditions, and the difference was statistically significant with χ2 = 57.99 (1) p < 0.001. 
  
Nature of Debilitating Conditions Qualifying Patients Count Percent 
Unique conditions† 22,357 77.20% 
Cancer 467 1.6% 
Hepatitis C 605 2.1% 
Cachexia 34 0.1% 
Seizures 233 0.8% 
Glaucoma 272 0.9% 
Sclerosis 7 0.0% 
Alzheimers 9 0.0% 
Severe and chronic pain 19,631 67.7% 
Muscle Spasms 420 1.4% 
HIV/AIDS 148 0.5% 
Crohn's Disease 142 0.5% 
Nausea 389 1.3% 
Multiple conditions‡ 6,620 22.8% 
Two conditions 5,379 18.6% 
Three conditions 1,090 3.8% 
Four conditions 131 0.5% 
Five conditions 19 0.1% 
Six conditions 1 0.0% 
State Totals 28,977 100% 
†Conditions are unique as in, of the 28,977 qualifying patients 467 indicated cancer as the 
only debilitating medical condition. 
‡Multiple conditions are two or more conditions specified by a qualified patient as in, of the 
28,977 qualifying patients 6,620 indicated having at least two or more of the listed 
debilitating conditions. 
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Figure 4. Debilitating medical conditions by age of the qualifying patient 
 
Figure 5. Debilitating medical conditions by gender of the qualifying patient 
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Table 7 gives an overview of debilitating medical conditions for QPs less than 18 years of age in 
order of frequency. In 50% of the cases (n = 10) “any debilitating medical condition that results 
in severe and chronic pain” was listed as a unique debilitating condition, followed by 25% (n = 
5) of the cases with two or more debilitating conditions, followed by 10% (n = 2) indicating 
nausea. 
Table 7. Debilitating medical conditions for qualifying patients who are minors 
 
The AMMA allows (see A.R.S. §36-2804.02(B)) individual QPs to be notified of any clinical 
studies on voluntary basis. During April 2011 to June 2012, out of the 28,977 QPs, 10,172 
(~35%) QPs requested to be notified of clinical studies. Table 8 provides an overview of the 
notifications of clinical studies by QP’s age, gender, and debilitating conditions. There were two 
important findings concerning QP’s selection of notification for clinical studies. First, females 
were 11% more likely than males to request clinical study notifications, and this difference was 
statistically significant χ2 = 15.28 (1) p < 0.001. Second, QPs with two or more conditions were 
20% more likely than those with one unique debilitating medical condition to request clinical 
study notifications, and this difference was statistically significant χ2 = 69.38 (1) p < 0.001. This 
finding was consistent with the earlier finding on gender differences in debilitating conditions 
among QPs that suggested that females were more likely than males to report two or more 
debilitating conditions and hence, the ‘propensity’ to request clinical study notifications was 
higher among females than males. 
Nature of Debilitating Condition 
Minor Qualifying Patients   
(<18 years) 
Count Percent 
Unique conditions† 15 75.0% 
Cancer 1 5.0% 
Hepatitis C 0 0.0% 
Cachexia 0 0.0% 
Seizures 0 0.0% 
Glaucoma 0 0.0% 
Sclerosis 0 0.0% 
Alzheimers 0 0.0% 
Severe and chronic pain 10 50.0% 
Muscle Spasms 1 5.0% 
HIV/AIDS 0 0.0% 
Crohn's Disease 1 5.0% 
Nausea 2 10.0% 
Multiple conditions‡ 5 25.0% 
State Totals 20 100% 
†Conditions are unique as in, of the 20 minor qualifying patients 10 indicated "severe and 
chronic pain" as the only debilitating medical condition. 
‡Multiple conditions are two or more conditions specified by a qualified patient as in, of the 
20 qualifying patients 5 indicated having at least two of the listed debilitating conditions. 
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Table 8. Notification of clinical studies by qualifying patient’s age, gender, and debilitating 
medical conditions 
 
3.3 Registry Identification Card(s) Revoked   
During the time period of other data reflected in this report, one Qualifying Patient Registry 
Identification Card was revoked and six Designated Caregiver Registry Identification Cards were 
revoked (for two total designated CGs who were issued more than one card).   
There are several types of revocations for Registry Identification Cards.   
• Designated Caregiver Revocations (Excluded Felony Offenses) – ADHS will seek a 
revocation when a designated CG has been found to have an excluded felony offense and 
is thus prohibited by statute to be a CG under the AMMA.   
• Law Enforcement Revocations – A revocation may be sought when ADHS receives 
information from a law enforcement entity that a cardholder has violated a provision(s) 
under the AMMA.    
• Credit Card Dispute Revocations – A revocation may be sought when an applicant has 
disputed the credit card charge for the application fee.  ADHS may seek to revoke the 
card (once the funds have been returned to the credit card company). 
Qualifying patient characteristics 
Clinical study notification 
Yes  
(n = 10,172) 
 No 
(n = 18,805) 
Count Percent   Count Percent 
Age (in years) 
<18 yrs  5 0.0%  15 0.1% 
18-30 yrs 2,488 24.5%  5190 27.6% 
31-40 yrs 2,106 20.7%  4005 21.3% 
41-50 yrs 1,928 19.0%  3312 17.6% 
51-60 yrs 2,272 22.3%  3878 20.6% 
61-70 yrs 1,178 11.6%  2065 11.0% 
71-80 yrs  164 1.6%  288 1.5% 
81+ yrs 31 0.3%  52 0.3% 
Gender†     
Females 2,844 28.0%  4,858 25.8% 
Males 7,328 72.0%  13,947 74.2% 
Debilitating conditions‡      
Unique condition 7,564 74.4%  14,793 78.7% 
Two or more conditions 2,608 25.6% 4,012 21.3% 
†Statistically significant difference between females and males. Females more likely than 
males to elect for for clinical study notifications. 
‡Statistically significant difference between qualifying patients with only one unique 
condition compared to those with two or more. QPs with two or more were more likely than 
those with only one condition to elect for clinical study notifications. 
17,902 
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3.4 Characteristics of Physicians Providing Written Certifications 
Table 9 on the following page provides an overview of the total 
number of medical marijuana certifications during April 2011 
to June 2012. The total certifications in the table reflect the 
total number of patients certified by each physician type. Four-
hundred seventy five (n = 475) physicians certified 28,977 
patients during this time period with an overall average of 61 
patients per physician. A closer examination of Table 9 
indicates that 80 NMDs certified 18,057 patients during this 
time period with an average certification of 226 patients per 
NMD, while 332 MDs certified 8,574 patients with an average 
of 26 certifications per MD during the same time period. 
Similarly, 61 DOs certified 2,329 patients with an average certification of 38.2 per DO, and two 
HMDs certified 17 patients with an average of 8.5 per HMD.  
It is evident from Table 9 that the distribution is heavily skewed towards a select few categories 
of physicians. Sixty-two percent of the patient certifications (18,057 / 28,977) were issued by 
NMDs, followed by approximately 30% (8,574 / 28,977) by MDs; although, MDs accounted for 
almost 70% (332 / 475) of the total physician certifiers.  
To evaluate the most frequent physician certifiers of patients, a 95th percentile was used as a cut-
off. Because only two HMDs completed a total of 17 patient certifications they were excluded 
from the analysis. Based on this criterion, the “24 most frequent physician certifiers” were 
identified and are displayed in Table 8. For instance, six MDs certified 5,279 patients accounting 
to approximately 61% of the total patient certifications in the MD category, while 17 NMDs 
accounted for 14,128 patient certifications accounting to approximately 78% of the total patient 
certifications in the NMD category. One DO accounted for 1,749 patient certifications 
accounting for 75% of the total patient certifications in the DO category. In total, 24 physicians 
certified over 21,000 patients that accounted for almost 75% of the total patient certifications.
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Table 9. Characteristics of physician certifications by type/specialization 
 
 
Counts of 
physician 
certifiers†
Total number of 
certifications by 
physician type‡
Average 
number of 
certifications§
Total number of 
eligible 
physician 
certifiers in the 
State¶
Rate* 
(Certifiers per 
1000 
physicians)
Counts of most 
frequent 
physician 
certifiers
Number of 
certifications by 
physician type
Percent of total 
certificationsφ
Doctor of Medicine (MD) 332 8,574 25.8 22,111 15.0 6 5,279 61.6
Doctor of Naturopathic Medicine (NMD) 80 18,057 225.7 1,765 45.3 17 14,128 78.2
Doctor of Osteopathic Medicine (DO) 61 2,329 38.2 2,594 23.5 1 1,749 75.1
Doctor of Homeopathic Medicine (HMD) 2 17 8.5 84 23.8 NA NA NA
Overall State Totals 475 28,977 61.0 24,789 19.2 24 21,156 73.0
Type of Physician Certifier
Medical Marijuana certifications during April 2011 to June 2012 24 most frequent certifiers of Medical Marijuana
†Counts are unique by type of physician certifiers and are identified using license number.
‡ Total number of physician certifications for patients during April 2011 and June 2012. For example 332 MDs certified 8,574 patients and 80 NMDs certified 18,057 patients.
§Average number of certifications is total number of certifications in each category divided by the unique count of physicians in that category (i.e. 8,574/332 = 25.83). On average each 
MD certified by 26 patients.
¶Data for total number of physicians is periodically obtained from Arizona Medical Board, Arizona Board of Naturopathic Medicine, Arizona Board of Homeopathic Medicine. The total 
numbers reflect data available as of May 2012 of active licensees.
*Rates are calculated as the unique count of physicians who provided certifications to medical marijuana patients divided by total number of eligible physicians in that category (for 
example, 332/22,111 = 15.02) per 1000.
φPercent of total certifications reflects the  total number of certifications by most frequent physician certifiers divided by total number of physician certifications completed during the time-
period. For example, four MDs accounted for 61% of the total certifications in the MD category (i.e. 5,279/8,574).
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Figure 6 below displays the most frequent physician certifiers by type to further illustrate the 
point made in Table 9.  
Figure 6. Most frequent recommending physicians by licensing board 
 
Table 10 on the following page lists the most frequent recommending physicians in order of 
number of certifications from April 2011 to June 2012. On a bi-annual basis, ADHS conducts an 
analysis of the most frequent physician certifiers and works with the Arizona Board of Pharmacy 
to assess whether these certifying physicians have been accessing the controlled substances 
database. Based on the recommendations from the Arizona Board of Pharmacy, each Arizona 
physician licensing board is notified of any discrepancies and possible further action.  Since the 
program’s inception in April 2011, ADHS has referred 11 physicians to the respective physician 
licensing boards for this issue.  
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Table 10. Twenty-four most frequent recommending physicians of medical marijuana 
 
Table 11 on the following page provides an overview of the physician recommendations for 
different debilitating medical conditions. The counts exclude HMDs due to small sample size. As 
noted earlier, severe and chronic pain is consistently the highest reported debilitating medical 
condition irrespective of the physician type. However, approximately 78% of the DOs (n = 
1,809) recommended severe and chronic pain as a unique debilitating medical condition 
compared to MDs (~66%) and NMDs (~67%). Both MDs (~26%) and NMDs (~23%) 
recommended two or more debilitating medical conditions, while only 14% of the DOs 
recommended two or more conditions.      
 
24 Most Frequent Certifiers of Medical Marijuana 
# Physician type Patients certified Percent within most frequent 
1 NMD 2,557 12.1% 
2 DO 1,749 8.3% 
3 NMD 1,561 7.4% 
4 MD 1,286 6.1% 
5 NMD 1,225 5.8% 
6 MD 1,079 5.1% 
7 MD 1,077 5.1% 
8 NMD 1,068 5.0% 
9 MD 882 4.2% 
10 NMD 852 4.0% 
11 NMD 754 3.6% 
12 NMD 720 3.4% 
13 NMD 668 3.2% 
14 NMD 668 3.2% 
15 NMD 665 3.1% 
16 NMD 592 2.8% 
17 NMD 572 2.7% 
18 MD 515 2.4% 
19 NMD 504 2.4% 
20 NMD 474 2.2% 
21 MD 440 2.1% 
22 NMD 436 2.1% 
23 NMD 433 2.0% 
24 NMD 379 1.8% 
Total Certifications§  21,156 100% 
§These certifications account to 73 percent of all the certifications during April 2011 to 
June 2012.  
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Table 11. Debilitating medical conditions by recommending physician type 
 
 
3.5 Registered Non-Profit Medical Marijuana Dispensaries 
From April 14, 2011 through June 2012, ADHS did not issue any certificates for non-profit 
medical marijuana dispensaries.  ADHS will report these required data elements in the second 
annual report.  
3.6 Non-Profit Medical Marijuana Dispensary Agents 
From April 14, 2011 through June 2012, ADHS did not issue any DA Registry Identification 
Cards.  ADHS will report these required data elements in the second annual report.  
 
 
 
Nature of Debilitating Medical 
Conditions§ 
Physician Certifications for Debilitating Medical Conditions 
DO 
 
MD 
 
NMD 
Totals Percent 
Count Percent  Count Percent  Count Percent 
Cancer 49 2.1%
 
99 1.2%
 
318 1.8% 466 1.6%
Hepatitis C 30 1.3%
 
125 1.5%
 
450 2.5% 605 2.1%
Cachexia 7 0.3%
 
13 0.2%
 
14 0.1% 34 0.1%
Seizures 21 0.9%
 
51 0.6%
 
161 0.9% 233 0.8%
Glaucoma 29 1.2%
 
58 0.7%
 
185 1.0% 272 0.9%
Sclerosis 0 0.0%
 
1 0.0%
 
6 0.0% 7 0.0%
Alzheimers 1 0.0%
 
2 0.0%
 
6 0.0% 9 0.0%
Severe and chronic pain 1,809 77.7%
 
5,671 66.1%
 
12,144 67.3% 19,624 67.8%
Muscle spasms 28 1.2%
 
139 1.6%
 
253 1.4% 420 1.5%
HIV/AIDS 9 0.4%
 
46 0.5%
 
93 0.5% 148 0.5%
Crohn's disease 15 0.6%
 
29 0.3%
 
98 0.5% 142 0.5%
Nausea 16 0.7%
 
103 1.2%
 
270 1.5% 389 1.3%
Two or more debilitating conditions 315 13.5%
 
2,237 26.1%
 
4,059 22.5% 6,611 22.8%
Overall State Totals 2,329 100.0%  8574 100%  18,057 100% 28,960¶ 100.0%
§Conditions are unique debilitating medical conditions unless noted otherwise.
¶17 HMDs are not included in the totals. 
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At the close of its initial year in 
operation, ADHS has been 
administering the program to 
support Arizona residents for 
whom medical marijuana may 
provide therapeutic and 
palliative benefit. 
Discussion and Recommendations  
Since the program’s inception in April 14, 2011 until June 30, 2012, there were a total of 29,804 
active cardholders that included both QPs (n = 28,977) and CGs (n = 827). At the close of its 
initial year in operation, ADHS has been administering the 
program to support Arizona residents for whom medical 
marijuana may provide therapeutic and palliative benefit. The 
majority (n = 19,631; 67.7%) of the QPs indicated “severe and 
chronic pain” as the unique debilitating condition and 
approximately 7% of the patients had other conditions that 
included Cancer (n = 467; 1.6%), Hepatitis C (n = 605; 2.1%), 
Muscle Spasms (n = 420; 1.4%), and Nausea (n = 389; 1.3%).  
It is possible to estimate in further detail the ‘true incidence’ of 
debilitating medical conditions by examining other data 
available at ADHS. However, there are statutory restrictions that require ADHS to maintain 
confidentiality of the medical marijuana registry data. Any public health analysis of this data will 
be limited in scope, unless the Arizona Medical Marijuana Act (AMMA) statutory elements are 
amended (i.e. in furtherance of the act) to conduct any epidemiological analysis to understand 
public health and safety implications. For instance, although causality was difficult to determine, 
a recent study, found that residents of states with medical marijuana laws had higher likelihood 
(odds) of marijuana use (OR:1.92; 95% CI: 1.49–2.47) and marijuana abuse/dependence (OR: 
1.81; 95% CI: 1.22–2.67) than residents of states without such laws.9  
Since the passage of the law, in two instances (Laws 2011, Chapter 112 and Laws 2011, Chapter 
336), modifications to AMMA were put in place to clarify ADHS’ authority to share doctor 
information with the various medical boards and required ADHS to allow employer access to the 
medical marijuana database to verify if employees were valid cardholders.  Additionally, Laws 
2011, Chapter 94 modified the controlled substances database to include medical marijuana to 
allow physicians to make more informed decisions about patient care. Without these 
modifications, it would have been difficult to assess the high frequency physician certifications 
noted in this report and/or to report them to their respective medical boards. Results found in this 
report on frequent physician certifications raise concerns about high volume certifiers. 
Some of the findings in this report lend support to the following recommendations that can 
further improve administration of AMMA: 
Recommendation 1: Develop intensive training for physicians who are high volume certifiers in 
conjunction with respective licensing medical boards for better patient provider coordination and 
adherence to AMMA statutory requirements.  Leverage existing contracts with the Arizona 
Board of Pharmacy to more quickly identify physicians who may be making false attestations on 
physician certifications. 
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Recommendation 2: Given the overwhelming recommendations for patients with “severe and 
chronic pain”, explore the feasibility of further examining the nature of debilitating conditions. 
For instance, the current incident rate for cancer in Arizona (5-year average) was 390 per 
100,000 (CI: 387.8–392.1) with an average annual count of 25,432 cases.10 However, in the 
medical marijuana database there were only 467 patients with Cancer as a unique debilitating 
condition. 
Recommendation 3: Explore the feasibility of temporary suspensions of cards. For revocations, 
the current AMMA statute provides only two possibilities with a cardholder status as either 
active and/or revoked. For instance, during the reporting period there was one revocation for a 
QP and two revocations for designated CGs. In either case, there are a series of administrative 
actions that need to occur before a card is revoked, including the possibility of appeals through 
Administrative Hearing and Superior Court. During this time lag, a card remains in “active” 
status (i.e. the cardholders are protected by the AMMA) until a final decision is made; thus, 
providing immunity to potential misuse of AMMA provisions. 
Recommendation 4: Explore the feasibility of conducting epidemiological analysis of medical 
marijuana users through amendment of AMMA statute to understand public health and safety 
concerns. For instance, epidemiological analyses can shed light on: a) whether use of medical 
marijuana has an effect on opiate dependency; b) whether use of medical marijuana has an 
impact on motor vehicle traffic injuries; and (c) whether use of medical marijuana has an impact 
on pregnancy outcomes or breastfeeding.   
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Appendix A 
 
 
 
 
 
 
 
 
 
 
 
 
Medical Marijuana Fund  
Program Inception through FY 2012  
4/14/2011 to 6/30/2012 
Revenues: 
Application fee for a Registry Card $5,525,277
Application fee for a Dispensary $2,420,000
Total Revenues $7,945,277
Expenditures: 
Salaries, Wages and Benefits $570,972
Operating Expenditures $1,505,023
Capital Equipment Expenditures $304,464
Total Expenditures $2,380,459
Fund Balance $5,564,818
Note:  ADHS utilizes the fund balance to fulfill the program's outstanding obligations. See 
Program Project Contracts and Interagency Services Agreements Section for details.  
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Appendix B 
Arizona Medical Marijuana Program Governing Documents 
Arizona Revised Statutes (A.R.S.) that Govern the Arizona Medical Marijuana Program 
The Arizona Revised Statutes (A.R.S.) represent the statutory laws of the state of Arizona. The 
A.R.S. and the Arizona Medical Marijuana Rules each contain requirements applicable to the 
Arizona Medical Marijuana Program. Accordingly, to fully understand all the requirements 
applicable to the Arizona Medical Marijuana Program, the A.R.S. and the Arizona Medical 
Marijuana Rules should be read in conjunction with each other. 
A.R.S. Title 36 
CHAPTER ARIZONA MEDICAL MARIJUANA ACT
36-2801 Definitions 
36-2801.01 Addition of debilitating medical conditions
36-2802 Arizona Medical Marijuana Act; limitations
36-2803 Rulemaking 
36-2804 Registration and certification of nonprofit medical marijuana dispensaries
36-2804.01 Registration of nonprofit medical marijuana dispensary agents; notices; civil 
36-2804.02 Registration of qualifying patients and designated caregivers 
36-2804.03 Issuance of registry identification cards
36-2804.04 Registry identification cards
36-2804.05 Denial of registry identification card
36-2804.06  Expiration and renewal of registry identification cards and registration 
36-2805 Facility restrictions 
36-2806 Registered nonprofit medical marijuana dispensaries; requirements 
36-2806.01 Dispensary locations 
36-2806.02 Dispensing marijuana for medical use
36-2807 Verification system 
36-2808 Notifications to department; civil penalty
36-2809 Annual report 
36-2810 Confidentiality 
36-2811 Presumption of medical use of marijuana; protections; civil penalty 
36-2813 Discrimination prohibited
36-2814 Acts not required; acts not prohibited
36-2815 Revocation 
36-2816 Violations; civil penalty; classification
36-2817 Medical marijuana fund; private donations
36-2818 Enforcement of this act; mandamus
36-2819 Fingerprinting requirements
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Arizona Medical Marijuana Administrative Code (Rules) 
The rules in the Arizona Administrative Code (A.A.C.) that apply to the Medical Marijuana 
Dispensary portion of the Arizona Medical Marijuana Act were filed on April 11, 2012. ADHS 
accepted applications for Medical Marijuana Dispensary Registration Certificates from May 14 
through May 25, 2012. 
ADHS used an emergency rulemaking process to incorporate the changes required by a recent 
Superior Court Ruling. This process requires subsequent rulemaking using the regular 
rulemaking process.  An unofficial draft of the rules being made through regular rulemaking 
combines the amendments contained in the Express Rulemaking with the Medical Marijuana 
Program Rules. 
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Appendix C 
Random Selection Protocol for Dispensaries 
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Appendix D 
Independent Accountant’s Report on Applying Agreed-Upon Procedures 
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